We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Series of Lab-on-a-Chip Assays

By HospiMedica staff writers
Posted on 14 Mar 2006
Eighteen new or upgraded assay kits for RNA, DNA, and protein have been developed that offer improved sensitivity, sizing range, robustness, and sample matrix tolerance. More...


The Series II family of assay kits is designed for use with the Agilent 2100 bioanalyzer platform of Agilent Technologies (Palo Alto, CA, USA). In addition to improved specifications, the new kits have an extended shelf-life of a minimum of four months, which is expected to grow with further testing. There will be no need to purchase separate ladders for the RNA assay. The existing kits will be phased out by June 2006.

The Series II protein assays facilitate the replacement of time-consuming sodium dodecyl (lauryl) sulphate-polyacrylamide gel (SDS-PAGE) and capillary gel electrophoresis with much faster fluidic analyses. The Protein 230 kit features an increased sizing range, higher sensitivity and salt tolerance. The Protein 80 kit can be used for analyzing proteins from 5-80 kDa, making it suitable for reduced antibodies. Primary improvements to the three DNA Series II assays include better sizing and quantification, better sensitivity specifications, increased stability and robustness, and streamlined protocol. The RNA and protein kits are boxed in two parts for storage at 4 or -20ºC.



Related Links:
Agilent Technologies

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.